ANIK - Anika Therapeutics, Inc.

QQQ $ 620.19 $ -4.59 (-0.73 %)

DIA $ 483.80 $ 3.27 (0.68 %)

SPY $ 683.32 $ -1.47 (-0.21 %)

TLT $ 90.29 $ 0.34 (0.37 %)

GLD $ 386.60 $ 6.52 (1.72 %)

Previous Close

$ 10.13

Open

$ 10.09

Bid

$ 10.09 x 121

Ask

$ 10.12 x 1

Day's Range

$ 10.08 - $ 10.24

52 Week Range

$ 7.87 - $ 18.37

Volume

119,331

Average Volume

Market Cap

146.09M

Beta (5Y Monthly)

$ 0.89

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-05-2025	09-30-2025	10-Q
2	07-30-2025	06-30-2025	10-Q
3	05-09-2025	03-31-2025	10-Q
4	03-14-2025	12-31-2024	10-K
5	11-04-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	03-15-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	03-16-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	03-11-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-07-2021	03-31-2021	10-Q
20	03-05-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-07-2020	06-30-2020	10-Q
23	05-22-2020	03-31-2020	10-Q
24	03-06-2020	12-31-2019	10-K
25	10-28-2019	09-30-2019	10-Q
26	07-26-2019	06-30-2019	10-Q
27	05-06-2019	03-31-2019	10-Q
28	02-27-2019	12-31-2018	10-K
29	10-26-2018	09-30-2018	10-Q
30	07-31-2018	06-30-2018	10-Q
31	05-10-2018	03-31-2018	10-Q
32	02-27-2018	12-31-2017	10-K
33	10-27-2017	09-30-2017	10-Q
34	07-28-2017	06-30-2017	10-Q
35	05-04-2017	03-31-2017	10-Q
36	02-24-2017	12-31-2016	10-K
37	11-01-2016	09-30-2016	10-Q
38	08-01-2016	06-30-2016	10-Q
39	05-03-2016	03-31-2016	10-Q
40	03-10-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barrington Research Maintains Outperform o...
11/06/2025 20:19:59

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and raises the pric...

Anika Initiates $15M 10b5-1 Share Repurcha...
11/05/2025 12:18:11

Anika Therapeutics Q3 Adj. EPS $0.04 Beats...
11/05/2025 12:17:17

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

Barrington Research Maintains Outperform o...
09/23/2025 15:01:22

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and maintains $15 p...

Barrington Research Maintains Outperform o...
07/31/2025 11:45:46

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and lowers the pric...

12 Health Care Stocks Moving In Wednesday'...
07/30/2025 17:07:24

Anika Therapeutics Q2 Adj. EPS $(0.13) Bea...
07/30/2025 11:16:21

Anika Therapeutics (NASDAQ:ANIK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(...

$anika-therapeutics-topline-results-from-its-us-pivotal-trial-of-hyalofast-for-articular-knee-cartilage-defect-lesions-demonstrated-improvements-over-microfracture-but-missed-on-statistical-significance-of-the-pre-specified-co-primary-endpoints$

Anika Therapeutics Topline Results From It...
07/30/2025 11:10:58

Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specifie...

Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

Barrington Research Maintains Outperform o...
05/12/2025 11:45:57

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and lowers the pric...

Anika Therapeutics Q1 Adj. EPS $(0.06) Bea...
05/09/2025 11:11:53

Earnings Scheduled For May 9, 2025
05/09/2025 08:32:15

A Glimpse of Anika Therapeutics's Earnings...
05/08/2025 18:02:00

microsoft-to-rally-more-than-17-here-are-10-top-analyst-forecasts-for-thursday

Microsoft To Rally More Than 17%? Here Are...
03/13/2025 13:09:26

Barrington Research Maintains Outperform o...
03/13/2025 12:04:55

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and lowers the pric...

us-stocks-likely-to-open-lower-after-a-brief-respite-add-exposure-to-equities-amid-pullback-says-expert

US Stocks Likely To Open Lower After A Bri...
03/13/2025 09:52:38

U.S. stock futures fell again on Thursday after a brief respite on Wednesday, following a softer-than-expected inflation print.

why-intel-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket

Why Intel Shares Are Trading Higher By Ove...
03/13/2025 09:05:54

Earnings Scheduled For March 12, 2025
03/12/2025 08:32:26

Barrington Research Maintains Outperform o...
11/01/2024 15:13:39

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and lowers the pric...